Lung Cancer News and Research

Latest Lung Cancer News and Research

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

26 Sep 2017

NCI selects UTSW cancer researcher to receive Outstanding Investigator Award

The National Cancer Institute has selected UT Southwestern Medical Center cancer researcher Dr. Ralph DeBerardinis to receive its prestigious Outstanding Investigator Award.

22 Sep 2017

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate the immune system to destroy the main tumor as well as leftover microscopic cancer cells that may seed other tumors.

20 Sep 2017

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

The Cancer Prevention and Research Institute of Texas has awarded UT Southwestern researchers more than $34 million for cancer research and faculty recruitment, including support for programs in pancreatic cancer, lung cancer, breast cancer, and melanoma.

19 Sep 2017

Make Sense campaign aims to promote better quality of life for head and neck cancer survivors

On the advent of the 2017 Head and Neck Cancer Awareness Week, the European Cancer Patient Coalition invited patients and policy makers to gather at the European Parliament to promote better quality of life for cancer patients and survivors as part of the Make Sense Campaign.

19 Sep 2017

Simple blood test provides new treatment choices to lung cancer patients

A simple test which can detect gene mutations in tumour DNA from blood samples is giving new choices to lung cancer patients with faster diagnosis and improved access to life changing drugs.

15 Sep 2017

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos. But over the last several decades, other causes of the disease have emerged, including treatment with high-intensity therapeutic radiation and, more recently, an inherited genetic mutation.

14 Sep 2017

FDA grants approval for new biosimilar to treat multiple types of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

14 Sep 2017

Epigenetic changes triggered by cigarette smoke may be earliest step in lung cancer development

Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called "epigenetic" changes in the cells consistent with the earliest steps toward lung cancer development.

12 Sep 2017

PENTAX Medical and Hitachi Medical Systems Europe jointly launch new ultrasound video bronchoscope

PENTAX Europe, a healthcare industry leader in endoscopic imaging, and Hitachi Medical Systems Europe, a leading company in medical imaging, recently announced renewed joint collaborative efforts to enable further innovations in the development of endoscopic ultrasound (EUS).

11 Sep 2017

Abdominal weight found to be key predictor of cancer risk in postmenopausal women

Body fat distribution in the trunk is more important than body weight when it comes to cancer risk in postmenopausal women, according to a study presented at the ESMO 2017 Congress in Madrid.

11 Sep 2017

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Combination immunotherapy as second or third line treatment extends overall survival to at least 15 months in patients with pleural malignant mesothelioma, according to late-breaking results from the MAPS2 trial presented today at the ESMO 2017 Congress in Madrid.

11 Sep 2017

Scientists find new strategy for overcoming resistance to drugs in lung cancer patients

Research at the University of Southern Denmark has revealed that a new combination of clinically tested drugs inhibits the growth of tumors, thereby potentially improving patients' survival.

8 Sep 2017

Combination treatment provides positive results for people with advanced melanoma

In a two-year UCLA-led study, nearly two-thirds of people with advanced melanoma responded positively to a treatment that combines the immunotherapy drug pembrolizumab with a herpes virus called talimogene laherpareovec, or T-VEC.

8 Sep 2017

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

For many years, oncologists have known that cancers can secrete complex molecules into the blood and that levels of these molecules can be easily measured. These so-called 'tumor markers' are traditionally associated with a single dominant cancer type, for example Prostate Specific Antigen (PSA) linked to prostate cancer, Carcinoembryonic antigen (CEA) to colorectal cancer, CA125 to ovarian cancer, CA19.9 to pancreatic cancer and CA27.29 to breast cancer.

6 Sep 2017

Fluorescent dye imaging tool lights up benign brain tumors during surgery

An experimental imaging tool that uses a targeted fluorescent dye successfully lit up the benign brain tumors of patients during removal surgery, allowing surgeons to identify tumor tissue, a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania shows.

6 Sep 2017

High levels of suPAR protein shown to be likely cause of kidney damage in children

High levels of a protein known as suPAR, which has been shown to be a marker and likely cause of kidney damage, is as reliably predictive in children as in adults, according to results of a study published online today in JAMA Pediatrics, a clinical publication of the American Medical Association.

5 Sep 2017

Some thyroid cancer patients can safely delay surgery

Most people diagnosed with cancer want to start treatment as soon as possible, for fear that delaying care will allow their tumor to grow out of control.

31 Aug 2017

New method of genetic testing leads to successful targeting of MET fusion in lung cancer

There are many ways a gene can be altered and there are many genes that, when altered, can cause cancer. Testing individually for each possible alteration in every cancer-related gene is not feasible as it would require hundreds of individual tests and many, many thousands of dollars.

31 Aug 2017

‘Liquid biopsies’ may help predict prognosis of early-stage lung cancer patients

Cancer cells obtained from a blood test may be able to predict how early-stage lung cancer patients will fare, a team from the University of Michigan has shown.

30 Aug 2017

Lung Cancer News and Research

Latest Lung Cancer News and Research

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

NCI selects UTSW cancer researcher to receive Outstanding Investigator Award

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

Make Sense campaign aims to promote better quality of life for head and neck cancer survivors

Simple blood test provides new treatment choices to lung cancer patients

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

FDA grants approval for new biosimilar to treat multiple types of cancer

Epigenetic changes triggered by cigarette smoke may be earliest step in lung cancer development

PENTAX Medical and Hitachi Medical Systems Europe jointly launch new ultrasound video bronchoscope

Abdominal weight found to be key predictor of cancer risk in postmenopausal women

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Scientists find new strategy for overcoming resistance to drugs in lung cancer patients

Combination treatment provides positive results for people with advanced melanoma

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

Fluorescent dye imaging tool lights up benign brain tumors during surgery

High levels of suPAR protein shown to be likely cause of kidney damage in children

Some thyroid cancer patients can safely delay surgery

New method of genetic testing leads to successful targeting of MET fusion in lung cancer

‘Liquid biopsies’ may help predict prognosis of early-stage lung cancer patients

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in